Health Care & Life Sciences » Pharmaceuticals | NanoCarrier Co. Ltd.

NanoCarrier Co. Ltd. | Ownership

Companies that own NanoCarrier Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
JPMorgan Asset Management (Japan) Ltd.
2,698,800
5.85%
-366,200
0.09%
08/15/2018
Baillie Gifford & Co.
1,542,600
3.34%
0
0.01%
04/30/2018
Siemens Fonds Invest GmbH
106,300
0.23%
3,400
0.04%
04/30/2018
GO ETF Solutions LLP
45,300
0.1%
7,290
0.01%
02/28/2018
Asset Management One Co., Ltd.
38,499
0.08%
-61,700
0%
01/15/2018
SSgA Funds Management, Inc.
25,800
0.06%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
17,900
0.04%
0
0%
03/31/2018
Resona Bank Ltd. (Investment Management)
14,938
0.03%
14,938
0%
04/25/2017
UBS AG (Investment Management)
13,300
0.03%
0
0%
01/31/2018
BlackRock Investment Management (UK) Ltd.
2,400
0.01%
0
0%
12/31/2016

About NanoCarrier Co.

View Profile
Address
144-15 Chuo
Kashiwa Chiba 277
Japan
Employees -
Website http://www.nanocarrier.co.jp
Updated 07/08/2019
NanoCarrier Co., Ltd. engages in the research, development, and production of pharmaceutical products through the use of micellar nanoparticles technology. These products are mainly used for cancer therapy. The company was founded by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi on June 14, 1996 and is headquartered in Kashiwa, Japan.